海角社区

Weijing Sun, MD, FACP, is a Director of Division of Medical Oncology in University of Kansas School of Medicine, and an Associate Director of University of Kansas Cancer Center. He specializes in the treatment of colorectal cancer.

Dr. Sun is board-certified in internal medicine and medical oncology. He received his medical degree from Shanghai Medical College, Fudan University, in Shanghai. He completed his residency in internal medicine at Loyola University Medical Center in Maywood, Ill., and his hematology-oncology fellowship at the University of Pennsylvania in Philadelphia.

Dr. Sun is a member of the American Medical Association, the American Society of Clinical Oncology, the American Association of Cancer Research, the Eastern Cooperative Group of Oncology Gastrointestinal Cancer Core Committee, the American College of Physicians 鈥� Internal Medicine, the NCI Gastrointestinal Cancer Steering Committee Hepatobiliary Task Force, and serves on the American Society of Clinical Oncology Scientific Program and Membership Committee. In addition, Dr. Sun has been recognized on U.S. 海角社区 & World Report鈥檚 American Top Doctors list.

Debashish Bose, M.D., PhD, FACS, an experienced, well-respected surgeon, serves as Medical Director of The Center for Hepatobiliary Disease at Mercy as well as Associate Director of Surgical Oncology at Mercy in Baltimore, Maryland. He is Board Certified in General Surgery and offers particular expertise in advanced surgical techniques for pancreatic cancer and liver cancer.

Dr. Bose provides leading edge cancer treatment options, including minimally invasive and robotic surgery in the care of late-stage and complex oncologic disease. He and his colleagues treat benign and malignant tumors in the peritoneal and abdominal cavity, including:

路         Stomach and Gastrointestinal Tract Tumors and Cancer

路         Pancreatic and Neuroendocrine Tumors

路         Soft Tissue Sarcoma

路         Metastatic Colon Cancer

路         Liver Tumors

路         Adrenal Gland Cancer

Dr. Bose works in close collaboration with the liver and pancreatic experts at Mercy鈥檚 Institute for Digestive Health and Liver Disease to provide patients the best possible outcome for their diagnosis.

Mercy Medical Center鈥檚 renowned surgical oncologists teamed with the experience of its liver and pancreatic experts provide patients seeking care for pancreatic cancer one of the most comprehensive gastrointestinal cancer teams in the Mid-Atlantic region.

In addition to offering surgical expertise, Dr. Bose aims to provide cancer patients with the knowledge and information needed for them to better understand their specific diagnosis, treatment and outcomes. He has dedicated his career to becoming an ally and a resource for patients facing late-stage and complex cancers. He guides patients through the treatment process and helps them make decisions to optimize their care and regain hope for a better quality of life.

Second opinion consultation and collaborative care with partner physicians make Dr. Bose a trusted expert among both patients and colleagues. Gastroenterologists, medical oncologists and primary care physicians rely on Dr. Bose for his insights, surgical skill and commitment to improving cancer survival.

Dr. Debashish Bose actively participates in research and has been the recipient of the Ruth L. Kirschstein National Research Service Award (NRSA). He has served as Principle Investigator in studies related to pancreatic cancer. His work has been published in peer-reviewed articles, book chapters and abstracts, and he has made numerous presentations to foster clinical advances in surgical oncology.

Education & Fellowships

路         Fellowship: University of Texas MD Anderson Cancer Center

路         Residency: Johns Hopkins Hospital

路         Medical Degree: University of Maryland School of Medicine

Dr Jennifer M. Yeh is a decision scientist whose research focuses on improving health outcomes at the population level. She is an Assistant Professor of Pediatrics at Harvard Medical School and Boston Children’s Hospital. Dr Yeh has an M.S. in Health Policy and Management from the Harvard T.H. Chan School of Public Health and a PhD in Health Policy from Harvard University. She has extensive experience applying decision-analytic modelling and cost-effectiveness analysis methods to evaluate clinical guidelines and inform health policy. Her research identifies opportunities to improve cancer control efforts spanning across the cancer continuum from prevention to survivorship. She is funded by the National Cancer Institute (NCI), the National Institute of Child Health and Human Development (NICHHD), and the American Cancer Society (ACS).

 
Dr. David Bajor, is an oncologist in Cleveland, Ohio and is affiliated with multiple hospitals in the area, including  and . He received his medical degree from Case Western Reserve University School of Medicine and has been in practice between 11-20 years.